Ownership Submission
FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Hacker Howard
2. Date of Event Requiring Statement (Month/Day/Year)
03/01/2019
3. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [THC]
(Last)
(First)
(Middle)
1445 ROSS AVENUE, SUITE 1400
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
EVP, Chief Compliance Officer
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

DALLAS, TX 75202
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 2,434
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
2016 May Restricted Stock Units   (1)   (1) Common Stock (2) 4,032 $ (2) D  
2016 May Performance-Based Restricted Stock Units   (3)   (3) Common Stock (2) 2,188 $ (2) D  
2017 March Restricted Stock Units   (4)   (4) Common Stock (2) 1,756 $ (2) D  
2017 March Performance Stock Options (Right to Buy)   (5) 03/01/2027 Common Stock 11,736 $ 18.99 D  
2018 February Restricted Stock Units   (6)   (6) Common Stock (2) 3,237 $ (2) D  
2018 February Performance Stock Options (Right to Buy)   (7) 02/28/2028 Common Stock 11,326 $ 20.6 D  
2019 February Restricted Stock Units   (8)   (8) Common Stock (2) 3,539 $ (2) D  
2019 February Performance Stock Options (Right to Buy)   (9) 02/27/2029 Common Stock 8,007 $ 28.26 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Hacker Howard
1445 ROSS AVENUE
SUITE 1400
DALLAS, TX 75202
      EVP, Chief Compliance Officer  

Signatures

Anthony L. Shoemaker, as Attorney-in-Fact for Howard Hacker 03/11/2019
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) These time-based restricted stock units vest in full on May 31, 2019.
(2) Restricted stock units are settled in shares of the Company's common stock upon vesting.
(3) On May 31, 2016, the reporting person received a target grant of 5,184 performance-based restricted stock units that were subject to the Company's achievement of specified performance goals for the three year period that ended on December 31, 2018. The actual number of stock units that could vest ranged from 0% to 200% of the target unit amount. The performance goals were achieved in part, and 42.2% of the target grant was awarded; therefore, 2,188 restricted stock units will vest and settle on May 31, 2019.
(4) These time-based restricted stock units vest in full on March 1, 2020.
(5) These performance-based stock options will vest on March 1, 2020, as the stock price performance condition has been satisfied.
(6) Half of these time-based restricted stock units vest on each of February 28, 2020 and 2021.
(7) These performance-based stock options will vest on February 28, 2021, as the stock price performance condition has been satisfied.
(8) One-third of these time-based restricted stock units vest on each of February 27, 2020, 2021 and 2022.
(9) These performance-based stock options vest on February 27, 2022, subject to the satisfaction of a stock price performance condition requiring the Company's common stock price to close at or above $35.33 per share for any 20 consecutive trading days during the three-year period following the date of grant, which was February 27, 2019.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.